Arcutis Biotherapeutics, Inc. Director Howard G. Welgus is set to sell 10,000 shares of common stock on 10/01/2024, with an aggregate market value of $92,616. The shares were originally acquired on 06/04/2018 through a stock option exercise from Arcutis Biotherapeutics Inc, with a cash payment made on the same date. This upcoming sale follows a recent pattern of transactions by Welgus, who has sold 20,000 shares in the past three months, generating total gross proceeds of $206,390.

Arcutis Biotherapeutics, Inc. Director Howard G. Welgus is set to sell 10,000 shares of common stock on 10/01/2024, with an aggregate market value of $92,616. The shares were originally acquired on 06/04/2018 through a stock option exercise from Arcutis Biotherapeutics Inc, with a cash payment made on the same date. This upcoming sale follows a recent pattern of transactions by Welgus, who has sold 20,000 shares in the past three months, generating total gross proceeds of $206,390.